Answers are grounded in this paper and cite their sources.
The study demonstrates dermal absorption differences between conventional and nano formulations of tebuconazole in rats, indicating formulation type impacts toxicokinetics.
This study demonstrates that formulation type and particle size influence the dermal absorption and toxicokinetics behavior of tebuconazole in rats. The results provide quantitative toxicokinetics data that improve the understanding of dermal exposure to nano-formulated fungicides.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: